Truist Financial Cuts Aveanna Healthcare (NASDAQ:AVAH) Price Target to $9.00

Aveanna Healthcare (NASDAQ:AVAH) had its target price cut by Truist Financial from $10.00 to $9.00 in a research report report published on Friday morning,Benzinga reports. They currently have a hold rating on the stock.

Several other research firms also recently commented on AVAH. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. UBS Group boosted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, January 15th. Royal Bank Of Canada upped their price objective on Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research note on Thursday, January 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Finally, Barclays boosted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $10.81.

Aveanna Healthcare Stock Up 2.8%

Shares of AVAH opened at $6.52 on Friday. The company has a debt-to-equity ratio of 6.62, a quick ratio of 1.32 and a current ratio of 1.32. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32. The stock has a market capitalization of $1.42 billion, a price-to-earnings ratio of 6.39 and a beta of 2.07. The stock has a fifty day moving average of $7.84 and a 200-day moving average of $8.49.

Insider Transactions at Aveanna Healthcare

In other news, CFO Matthew Buckhalter sold 13,512 shares of the stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $97,421.52. Following the completion of the sale, the chief financial officer owned 529,243 shares of the company’s stock, valued at approximately $3,815,842.03. This represents a 2.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jeff Shaner sold 173,225 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25. Following the transaction, the chief executive officer owned 2,650,892 shares of the company’s stock, valued at $19,112,931.32. This trade represents a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 998,595 shares of company stock worth $7,567,770. 7.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Teacher Retirement System of Texas raised its stake in Aveanna Healthcare by 232.8% during the third quarter. Teacher Retirement System of Texas now owns 224,375 shares of the company’s stock worth $1,990,000 after buying an additional 156,947 shares during the last quarter. AustralianSuper Pty Ltd bought a new stake in Aveanna Healthcare during the third quarter valued at $15,743,000. Assenagon Asset Management S.A. bought a new stake in Aveanna Healthcare during the third quarter valued at $7,356,000. Squarepoint Ops LLC grew its holdings in Aveanna Healthcare by 207.0% during the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock worth $2,510,000 after acquiring an additional 323,656 shares during the period. Finally, Algert Global LLC grew its holdings in Aveanna Healthcare by 120.1% during the 3rd quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after acquiring an additional 557,898 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results beat consensus — revenue grew strongly year‑over‑year and the company topped EPS and revenue estimates, providing fundamental support for the stock. Press Release
• Positive Sentiment: Raymond James upgraded AVAH to “strong-buy” and set a $13 price target, which is a bullish catalyst and likely helping intraday buying interest. Finviz item
• Neutral Sentiment: BMO trimmed its price target from $11 to $10 but maintained an “outperform” rating — a modest pullback in upside but not a negative rating change. Benzinga
• Neutral Sentiment: Aveanna issued 2026 guidance and a growth outlook; the details are being parsed by investors and helped explain the mixed market reaction (earnings beat vs. cautious forward commentary). TipRanks
• Neutral Sentiment: Reported short‑interest entries show anomalous “0 shares”/NaN data for March (data likely erroneous), so short‑interest signals are not meaningful right now.
• Negative Sentiment: Truist lowered its price target to $9 and moved to a “hold” rating, reducing analyst support and putting downside pressure on the stock. Benzinga
• Negative Sentiment: Market headlines flagged that Aveanna’s revenue outlook/trend in guidance trailed some consensus expectations, which prompted a pullback in some coverage and weighed on sentiment. MSN

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.